IP Library › Granted Patent US 7,060,479
Granted Patent B2
US 7,060,479 · App. 09/876,997 · Granted Jun 13, 2006

Full-length human cDNAs encoding potentially secreted proteins

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,060,479
App. No.
09/876,997
Granted
Jun 13, 2006
Kind
B2
Abstract

The invention concerns GENSET polynucleotides and polypeptides. Such GENSET products may be used as reagents in forensic analyses, as chromosome markers, as tissue/cell/organelle-specific markers, in the production of expression vectors. In addition, they may be used in screening and diagnosis assays for abnormal GENSET expression and/or biological activity and for screening compounds that may be used in the treatment of GENSET-related disorders.

Claims (7)

1. A purified and isolated polypeptide comprising the amino acid sequence of SEQ ID NO: 399.

2. The polypeptide of claim 1 , wherein said polypeptide consists of the amino acid sequence of SEQ ID NO: 399.

3. A purified and isolated polypeptide comprising an amino acid sequence encoded by a human cDNA of Clone 160-40-1-0-H4-CS in ATCC accession number PTA-1218.

4. The polypeptide of claim 1 , wherein said polypeptide is a phosphatase.

5. The polypeptide of claim 3 , wherein said polypeptide is a phosphatase.

6. The polypeptide of claim 4 , wherein said polypeptide catalyzes the conversion of phosphatidic acid into diacylglycerol.

7. The polypeptide of claim 5 , wherein said polypeptide catalyzes the conversion of phosphatidic acid into diacylglycerol.

Assignments (1)
CHANGE OF NAME Recorded Aug 3, 2005
From: GENSET S.A.
To: SERONO GENETICS INSTITUTE S.A.
Reel/Frame 016348/0865 →